{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T20:37:03Z","timestamp":1769287023041,"version":"3.49.0"},"posted":{"date-parts":[[2025,12,2]]},"group-title":"Allergy and Immunology","reference-count":71,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.medrxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Cholera is a critical global health threat, with significant impact on low- and middle-income countries. Clinical surveillance is limited by non-specific symptoms, dependence on care-seeking, and availability of microbiological diagnostics, making burden estimation difficult. Serosurveillance is a potential solution, but the design and interpretation of cross-sectional seroepidemiological studies are currently limited by a lack of knowledge of longitudinal antibody trajectories.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>\n                    We systematically reviewed literature from 1980 to 2025 containing longitudinal antibody measurements in humans following exposure to\n                    <jats:italic>Vibrio cholerae O1\/O139<\/jats:italic>\n                    and associated vaccines.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>51 studies representing adults and children from 1 low-income (1 study), 5 lower-middle-income (24 studies), 3 upper-middle-income (5 studies) and 5 high-income (21 studies) countries were included. 16 studies followed natural infection, 36 involved vaccination, and 6 were human challenge models, with some overlap. Antibody responses following infection were significantly higher than those induced by vaccination, particularly against O-specific polysaccharide (OSP). Younger children exhibited higher peak fold-change IgA responses to Cholera-toxin B-subunit (CTB) than older children and adults across infection and vaccine studies. Following vaccination, individuals from high-income countries showed higher IgA, IgG, and vibriocidal fold-change responses compared to those from lower-income settings. Limited data from challenge studies revealed slower decay of IgG compared to IgA and IgM.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>\n                    This review enhances our understanding of longitudinal immune responses to\n                    <jats:italic>V. cholerae<\/jats:italic>\n                    , highlighting variability in antibody kinetics across age groups, geographic regions, and study designs, and informs the design and interpretation of seroepidemiological studies of cholera.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Key Messages<\/jats:title>\n                  <jats:list list-type=\"bullet\">\n                    <jats:list-item>\n                      <jats:p>\n                        ur Research Question: We aimed to systematically review longitudinal antibody responses in humans following natural infection, vaccination, or challenge with\n                        <jats:italic>Vibrio cholerae<\/jats:italic>\n                        O1\/O139, to inform interpretation of cross-sectional seroepidemiologic studies.\n                      <\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>We Found: We found that antibody responses vary significantly by exposure type, age group, and geographic setting, with infection inducing stronger and longer-lasting responses than vaccination, and younger children showing higher IgA responses to CTB compared to older children and adults.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>it is Important: These findings highlight variability in immune responses across populations and underscore the need for tailored approaches to accurately estimate cholera burden and guide global control strategies.<\/jats:p>\n                    <\/jats:list-item>\n                  <\/jats:list>\n                <\/jats:sec>","DOI":"10.64898\/2025.11.27.25341157","type":"posted-content","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:03:25Z","timestamp":1765278205000},"source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Antibody Responses to\n                  <i>Vibrio cholerae<\/i>\n                  Across Natural Infection, Vaccination, and Challenge: A Systematic Review"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4970-6138","authenticated-orcid":false,"given":"Aparna","family":"Mangadu","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christy","family":"Clutter","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenadee","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatum","family":"Heiner","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6891-2290","authenticated-orcid":false,"given":"Shubhanshi","family":"Trivedi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Saruar","family":"Bhuiyan","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben J","family":"Brintz","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Department of Internal Medicine, Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew S.","family":"Azman","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA"},{"name":"Institute of Global Health, University of Geneva, Geneva, Switzerland"},{"name":"Division of Tropical and Humanitarian Medicine and Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6105-7295","authenticated-orcid":false,"given":"Benjamin F.","family":"Arnold","sequence":"additional","affiliation":[{"name":"Francis I. Proctor Foundation and Department of Ophthalmology, University of California, San Francisco, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8401-0801","authenticated-orcid":false,"given":"Daniel T.","family":"Leung","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah, USA"},{"name":"Division of Microbiology and Immunology, Department of Pathology, Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026012302550725000_2025.11.27.25341157v2.1","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abc6347"},{"issue":"7","key":"2026012302550725000_2025.11.27.25341157v2.2","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3201\/eid2407.171928","article-title":"Integrated Serologic Surveillance of Population Immunity and Disease Transmission","volume":"24","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2026012302550725000_2025.11.27.25341157v2.3","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau6242"},{"key":"2026012302550725000_2025.11.27.25341157v2.4","unstructured":"Cholera [Internet]. [cited 2025 June 6]. Available from: https:\/\/www.who.int\/health-topics\/cholera"},{"key":"2026012302550725000_2025.11.27.25341157v2.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00330-0"},{"issue":"12","key":"2026012302550725000_2025.11.27.25341157v2.6","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3390\/microorganisms12122504","article-title":"Cholera Outbreaks in Low- and Middle-Income Countries in the Last Decade: A Systematic Review and Meta-Analysis","volume":"12","year":"2024","journal-title":"Microorganisms"},{"issue":"8","key":"2026012302550725000_2025.11.27.25341157v2.7","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1016\/S2666-5247(20)30141-5","article-title":"Vibrio cholerae O1 transmission in Bangladesh: insights from a nationally representative serosurvey","volume":"1","year":"2020","journal-title":"Lancet Microbe"},{"issue":"12 Suppl 2","key":"2026012302550725000_2025.11.27.25341157v2.8","first-page":"S742","article-title":"Modern History of Cholera Vaccines and the Pivotal Role of icddr,b","volume":"224","year":"2021","journal-title":"J Infect Dis"},{"issue":"7","key":"2026012302550725000_2025.11.27.25341157v2.9","doi-asserted-by":"crossref","first-page":"e1203","DOI":"10.1016\/S2214-109X(25)00107-X","article-title":"Protection from killed whole-cell cholera vaccines: a systematic review and meta-analysis","volume":"13","year":"2025","journal-title":"Lancet Glob Health"},{"key":"2026012302550725000_2025.11.27.25341157v2.10","doi-asserted-by":"publisher","DOI":"10.1258\/jrsm.96.3.118"},{"issue":"11","key":"2026012302550725000_2025.11.27.25341157v2.11","doi-asserted-by":"crossref","first-page":"e0189825","DOI":"10.1128\/mbio.01898-25","article-title":"Expanding cholera serosurveillance to vaccinated populations","volume":"16","year":"2025","journal-title":"mBio"},{"issue":"6","key":"2026012302550725000_2025.11.27.25341157v2.12","doi-asserted-by":"crossref","first-page":"e0190022","DOI":"10.1128\/mbio.01900-22","article-title":"Identifying Recent Cholera Infections Using a Multiplex Bead Serological Assay","volume":"13","year":"2022","journal-title":"mBio"},{"issue":"1","key":"2026012302550725000_2025.11.27.25341157v2.13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02601736","article-title":"Immunological cross-reactivity betweenEscherichia coli heat-labile enterotoxin and cholera toxin A and B subunits","volume":"2","year":"1979","journal-title":"Current Microbiology"},{"issue":"11","key":"2026012302550725000_2025.11.27.25341157v2.14","doi-asserted-by":"crossref","first-page":"e0189825","DOI":"10.1128\/mbio.01898-25","article-title":"Expanding cholera serosurveillance to vaccinated populations","volume":"16","year":"2025","journal-title":"mBio"},{"key":"2026012302550725000_2025.11.27.25341157v2.15","doi-asserted-by":"crossref","first-page":"1473637","DOI":"10.3389\/fimmu.2024.1473637","article-title":"Binding to the neonatal Fc receptor enhances the pathogenicity of anti-desmoglein-3 antibodies in keratinocytes","volume":"15","year":"2024","journal-title":"Front Immunol"},{"issue":"6","key":"2026012302550725000_2025.11.27.25341157v2.16","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.4161\/hv.29199","article-title":"Maximizing protection from use of oral cholera vaccines in developing country settings","volume":"10","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"2026012302550725000_2025.11.27.25341157v2.17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2217\/fmb-2017-0128","article-title":"Causes of impaired oral vaccine efficacy in developing countries","volume":"13","year":"2018","journal-title":"Future Microbiol"},{"key":"2026012302550725000_2025.11.27.25341157v2.18","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7007-8-129"},{"key":"2026012302550725000_2025.11.27.25341157v2.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.epidem.2024.100806"},{"key":"2026012302550725000_2025.11.27.25341157v2.20","doi-asserted-by":"crossref","unstructured":"Davis KL , Nieznanski C , Maisha FM , Brintz BJ , Clutter CH , Alam MT , et al. Long-term Kinetics of Vibriocidal Antibody Responses After Vibrio cholerae Infection in the Democratic Republic of Congo. J Infect Dis. 2025 July 22;jiaf382.","DOI":"10.1101\/2025.02.26.25322966"},{"issue":"7","key":"2026012302550725000_2025.11.27.25341157v2.21","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1128\/iai.65.7.2676-2684.1997","article-title":"Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina","volume":"65","year":"1997","journal-title":"Infect Immun"},{"issue":"4","key":"2026012302550725000_2025.11.27.25341157v2.22","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1128\/iai.63.4.1336-1339.1995","article-title":"Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults","volume":"63","year":"1995","journal-title":"Infect Immun"},{"issue":"3","key":"2026012302550725000_2025.11.27.25341157v2.23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000234532","article-title":"IgG and IgA subclass distribution of antitoxin antibody responses after oral cholera vaccination or cholera disease","volume":"85","year":"1988","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"2026012302550725000_2025.11.27.25341157v2.24","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/151.2.236"},{"key":"2026012302550725000_2025.11.27.25341157v2.25","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.4.1126"},{"key":"2026012302550725000_2025.11.27.25341157v2.26","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau6242"},{"key":"2026012302550725000_2025.11.27.25341157v2.27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006376"},{"issue":"3","key":"2026012302550725000_2025.11.27.25341157v2.28","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1128\/CVI.00481-10","article-title":"Mucosal Immunologic Responses in Cholera Patients in Bangladesh","volume":"18","year":"2011","journal-title":"Clin Vaccine Immunol CVI"},{"key":"2026012302550725000_2025.11.27.25341157v2.29","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.13-0498"},{"issue":"1","key":"2026012302550725000_2025.11.27.25341157v2.30","first-page":"e00470","article-title":"The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae","volume":"24","year":"2017","journal-title":"Clin Vaccine Immunol CVI"},{"issue":"5","key":"2026012302550725000_2025.11.27.25341157v2.31","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1128\/CVI.05615-11","article-title":"Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh","volume":"19","year":"2012","journal-title":"Clin Vaccine Immunol CVI"},{"issue":"8","key":"2026012302550725000_2025.11.27.25341157v2.32","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1128\/CVI.05124-11","article-title":"Comparison of Memory B Cell, Antibody-Secreting Cell, and Plasma Antibody Responses in Young Children, Older Children, and Adults with Infection Caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh11","volume":"18","year":"2011","journal-title":"Clin Vaccine Immunol CVI"},{"issue":"5","key":"2026012302550725000_2025.11.27.25341157v2.33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/CVI.00647-15","article-title":"O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh","volume":"23","year":"2016","journal-title":"Clin Vaccine Immunol CVI"},{"key":"2026012302550725000_2025.11.27.25341157v2.34","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2012.12-0323"},{"key":"2026012302550725000_2025.11.27.25341157v2.35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007057"},{"issue":"1","key":"2026012302550725000_2025.11.27.25341157v2.36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1128\/CVI.00521-12","article-title":"Study of Avidity of Antigen-Specific Antibody as a Means of Understanding Development of Long-Term Immunological Memory after Vibrio cholerae O1 Infection","volume":"20","year":"2013","journal-title":"Clin Vaccine Immunol CVI"},{"key":"2026012302550725000_2025.11.27.25341157v2.37","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00868-09"},{"key":"2026012302550725000_2025.11.27.25341157v2.38","doi-asserted-by":"publisher","DOI":"10.1086\/591500"},{"issue":"3","key":"2026012302550725000_2025.11.27.25341157v2.39","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/iai.59.3.996-1001.1991","article-title":"Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans","volume":"59","year":"1991","journal-title":"Infect Immun"},{"issue":"8","key":"2026012302550725000_2025.11.27.25341157v2.40","doi-asserted-by":"crossref","first-page":"e0007634","DOI":"10.1371\/journal.pntd.0007634","article-title":"Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh","volume":"13","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"2026012302550725000_2025.11.27.25341157v2.41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003076"},{"key":"2026012302550725000_2025.11.27.25341157v2.42","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/143.6.818"},{"key":"2026012302550725000_2025.11.27.25341157v2.43","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)90335-2"},{"issue":"6","key":"2026012302550725000_2025.11.27.25341157v2.44","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1128\/iai.58.6.1620-1627.1990","article-title":"Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a","volume":"58","year":"1990","journal-title":"Infect Immun"},{"issue":"5","key":"2026012302550725000_2025.11.27.25341157v2.45","doi-asserted-by":"crossref","first-page":"e96499","DOI":"10.1371\/journal.pone.0096499","article-title":"Vibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, India","volume":"9","year":"2014","journal-title":"PloS One"},{"key":"2026012302550725000_2025.11.27.25341157v2.46","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.7.3680-3685.1999"},{"issue":"2","key":"2026012302550725000_2025.11.27.25341157v2.47","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/iai.44.2.439-444.1984","article-title":"Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae","volume":"44","year":"1984","journal-title":"Infect Immun"},{"issue":"11","key":"2026012302550725000_2025.11.27.25341157v2.48","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1128\/iai.57.11.3261-3264.1989","article-title":"Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults","volume":"57","year":"1989","journal-title":"Infect Immun"},{"key":"2026012302550725000_2025.11.27.25341157v2.49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1988.tb01474.x"},{"issue":"10","key":"2026012302550725000_2025.11.27.25341157v2.50","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1086\/342908","article-title":"Efficacy of atovaquone\/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines","volume":"35","year":"2002","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"2026012302550725000_2025.11.27.25341157v2.51","unstructured":"Chaicumpa W. Assessment of antibody responses and protective immunity in cholera vaccinated subjects. 2018;"},{"issue":"6","key":"2026012302550725000_2025.11.27.25341157v2.52","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.vaccine.2017.12.062","article-title":"Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR in healthy adults age 18-45","volume":"36","year":"2018","journal-title":"Vaccine"},{"issue":"11","key":"2026012302550725000_2025.11.27.25341157v2.53","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.vaccine.2019.01.077","article-title":"Age-related immunogenicity and reactogenicity of live oral cholera vaccine CVD 103-HgR in a randomized, controlled clinical trial","volume":"37","year":"2019","journal-title":"Vaccine"},{"issue":"6","key":"2026012302550725000_2025.11.27.25341157v2.54","doi-asserted-by":"crossref","first-page":"e0218353","DOI":"10.1371\/journal.pone.0218353","article-title":"Assessment of disease specific immune responses in enteric diseases using dried blood spot (DBS)","volume":"14","year":"2019","journal-title":"PloS One"},{"issue":"8","key":"2026012302550725000_2025.11.27.25341157v2.55","first-page":"e00098","article-title":"Antibody-Based Correlates of Protection Against Cholera Analysis of a Challenge Study in a Cholera-Na\u00efve Population","volume":"24","year":"2017","journal-title":"Clin Vaccine Immunol CVI"},{"issue":"10","key":"2026012302550725000_2025.11.27.25341157v2.56","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1128\/CVI.00341-13","article-title":"Antibody Avidity in Humoral Immune Responses in Bangladeshi Children and Adults following Administration of an Oral Killed Cholera Vaccine","volume":"20","year":"2013","journal-title":"Clin Vaccine Immunol CVI"},{"key":"2026012302550725000_2025.11.27.25341157v2.57","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(93)90125-H"},{"issue":"10","key":"2026012302550725000_2025.11.27.25341157v2.58","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1128\/iai.60.10.4430-4432.1992","article-title":"Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial","volume":"60","year":"1992","journal-title":"Infect Immun"},{"issue":"2","key":"2026012302550725000_2025.11.27.25341157v2.59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1128\/jcm.24.2.203-209.1986","article-title":"Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease","volume":"24","year":"1986","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2026012302550725000_2025.11.27.25341157v2.60","first-page":"861","article-title":"Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children Aged 2-5 Years in the United States","volume":"104","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"2026012302550725000_2025.11.27.25341157v2.61","doi-asserted-by":"crossref","first-page":"e0009743","DOI":"10.1371\/journal.pntd.0009743","article-title":"Longitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine","volume":"15","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"2026012302550725000_2025.11.27.25341157v2.62","doi-asserted-by":"crossref","unstructured":"Chowdhury F , Akter A , Bhuiyan TR , Biswas R , Firoj MG , Tauheed I , et al. Long-term sialidase-specific immune responses after natural infection with cholera: Findings from a longitudinal cohort study in Bangladesh. Front Immunol [Internet]. 2022 Dec 22 [cited 2025 Jul 3];13. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2022.1067737\/full","DOI":"10.3389\/fimmu.2022.1067737"},{"issue":"5","key":"2026012302550725000_2025.11.27.25341157v2.63","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4269\/ajtmh.22-0462","article-title":"An Age-stratified, Randomized Immunogenicity Trial of Killed Oral Cholera Vaccine with Delayed Second Dose in Cameroon","volume":"107","year":"2022","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"2026012302550725000_2025.11.27.25341157v2.64","doi-asserted-by":"crossref","first-page":"e0262239","DOI":"10.1371\/journal.pone.0262239","article-title":"Immunogenicity and waning immunity from the oral cholera vaccine (ShancholTM) in adults residing in Lukanga Swamps of Zambia","volume":"17","year":"2022","journal-title":"PloS One"},{"issue":"2","key":"2026012302550725000_2025.11.27.25341157v2.65","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/cid\/ciac782","article-title":"Co-administration of Oral Cholera Vaccine With Oral Polio Vaccine Among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference","volume":"76","year":"2023","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"2026012302550725000_2025.11.27.25341157v2.66","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.01232-20"},{"issue":"5","key":"2026012302550725000_2025.11.27.25341157v2.67","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.4269\/ajtmh.20-1576","article-title":"Long-Term Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Adolescents Aged 12-17 Years in the United States","volume":"104","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"2026012302550725000_2025.11.27.25341157v2.68","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/165.6.1042"},{"issue":"1","key":"2026012302550725000_2025.11.27.25341157v2.69","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4269\/ajtmh.19-0241","article-title":"Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children and Adolescents Aged 6-17 Years","volume":"102","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"2026012302550725000_2025.11.27.25341157v2.70","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.7.3390-3396.1998"},{"issue":"3","key":"2026012302550725000_2025.11.27.25341157v2.71","doi-asserted-by":"crossref","first-page":"e0056523","DOI":"10.1128\/msphere.00565-23","article-title":"Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants","volume":"9","year":"2024","journal-title":"mSphere"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2025.11.27.25341157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T10:55:20Z","timestamp":1769165720000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2025.11.27.25341157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":71,"URL":"https:\/\/doi.org\/10.64898\/2025.11.27.25341157","relation":{},"subject":[],"published":{"date-parts":[[2025,12,2]]},"subtype":"preprint"}}